Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new attempt to solve the scale-up problem for granulation using response surface methodology

S Ogawa1, T Kamijima, Y Miyamoto

  • 1Central Research Laboratories, Zeria Pharmaceutical Co., Ltd., Saitama, Japan.

Journal of Pharmaceutical Sciences
|March 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutralizing activity of human antibodies against the structural protein of human T-cell lymphotropic virus type I.

International journal of cancer·1992
Same author

Identification of one base deletion in exon IX of the protein C gene that causes a type I deficiency.

Thrombosis research·1992
Same author

Evaluation of an improved dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge in early breast cancer: results of a multicenter study.

Japanese journal of clinical oncology·1992
Same author

Transfer of plutonium to rat embryos in vivo and in vitro.

Journal of radiation research·1992
Same author

Purification of a new anticoagulant protein, calphobindin III, from human placenta.

The Tohoku journal of experimental medicine·1992
Same author

Inhibition of active oxygen generation by dipyridamole in human polymorphonuclear leukocytes.

European journal of pharmacology·1992

A novel mathematical approach using an integrated optimization function successfully addresses pharmaceutical granulation scale-up challenges. This method ensures consistent granule properties across different manufacturing scales, minimizing production issues.

Area of Science:

  • Pharmaceutical Manufacturing
  • Chemical Engineering
  • Process Optimization

Background:

  • Scale-up of pharmaceutical granulation processes from laboratory to production often leads to suboptimal binder solution formulations.
  • Binder solution characteristics are critical for achieving desired granule physical properties during manufacturing.
  • Existing methods struggle to maintain consistent formulation effectiveness across different production scales.

Purpose of the Study:

  • To develop and assess a new mathematical procedure for solving granulation scale-up problems.
  • To introduce an "integrated optimization function" for universal optimal formulation.
  • To validate the approach by comparing predicted and experimental results across scales.

Main Methods:

  • Granule preparation using a high-speed mixer granulator at 2-kg and 5-kg scales.

Related Experiment Videos

  • Development of a computerized optimizing technique based on response surface methodology.
  • Minimization of a newly introduced "integrated optimization function" to find scale-independent formulations.

    • Main Results:

    • Predicted yield, mean granule size, and granule size uniformity closely matched experimental data on both scales.
    • Optimized characteristics at the production scale aligned well with laboratory-scale findings.
    • The integrated optimization function yielded a universal optimal formulation unaffected by manufacturing scale.

    Conclusions:

    • The developed mathematical procedure effectively minimizes scale-up problems in pharmaceutical granulation.
    • The integrated optimization function offers a robust method for achieving consistent granule quality across manufacturing scales.
    • This approach holds significant potential for improving the efficiency and reliability of pharmaceutical production.